D DNLI
Denali Therapeutics Inc
$21.66
+3.04% (+$0.64)
Volume
2.18M
52W High
$23.77
52W Low
$12.58
Market Cap
$3.17B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.60
Whisper EPS
-$0.60
0.8% above consensus
Last Quarter
-$0.69
Current Streak
6 Beats
Avg Surprise (4Q)
+3.46%
Next Earnings Report
Reports in 56 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
+1.75%
Q1 2026
May 11, 2026
1-Day:
-1.07%
Q1 2026
May 7, 2026
1-Day:
-0.46%
5-Day:
-1.27%
Q1 2026
May 5, 2026
1-Day:
+7.88%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'23 | $1.3M | -64.4% | 100.0% | -8,981.5% | -$99.4M |
| Q2'23 | $294.1M | +460.5% | 100.0% | 58.0% | $183.4M |
| Q1'23 | $35.1M | -16.6% | 100.0% | -343.8% | -$109.8M |
| Q4'22 | $10.3M | -17.8% | 100.0% | -1,024.5% | -$98.7M |
| Q3'22 | $3.6M | -32.7% | 100.0% | -3,020.1% | -$103.3M |
| Q2'22 | $52.5M | +128.8% | 100.0% | -117.0% | -$58.8M |
| Q1'22 | $42.1M | +431.9% | 100.0% | -157.8% | -$65.2M |
| Q4'21 | $12.5M | -96.1% | 100.0% | -616.3% | -$75.3M |
Company Information
Symbol
DNLI
Company
Denali Therapeutics Inc
Market Cap
$3.17B
Next Earnings
Aug 10, 2026